103 days of hospitalization, the patient received 9 units of fresh frozen plasma and 15 units of packed red blood cells.
Since 1968, ERCP has evolved from a diagnostic to an almost exclusively therapeutic procedure for biliary and pancreatic disorders. 1 This procedure can be complicated by a variety of adverse events including acute pancreatitis, hemorrhage, cholangitis, cholecystitis, or perforation. In 1991, standardized consensus definitions for major complications of ERCP were introduced and are still widely used. 2 Of these complications, post-ERCP pancreatitis is the most frequent. It is usually clinically mild or moderate in severity but can be severe or even potentially fatal in about 10% of the cases. 3 The 2012 Revised Atlanta Classification defined acute pancreatitis as well as systemic and local complications of pancreatitis (eg, walled-off pancreatic necrosis). 4 In 2013, the International Association of Pancreatology and American Pancreatic Association recommended image--guided percutaneus (retroperitoneal) or endoscopic transluminal drainage as the optimal intervention for patients with suspected or confirmed infected necrotizing pancreatitis. 5 Our case is a reminder that a therapeutic ERCP may be the cause of severe acute necrotizing pancreatitis associated with a clinically significant complication such as massive hemorrhage and infection of pancreatic necrosis. 
